Salarius Pharmaceuticals Files S-1/A Update
Ticker: DCOY · Form: S-1/A · Filed: Apr 17, 2025 · CIK: 1615219
Sentiment: neutral
Topics: sec-filing, update, pharmaceutical
Related Tickers: SLRX
TL;DR
Salarius Pharma (SLRX) filed an S-1/A update, likely addressing SEC comments. Stay tuned for business/financial news.
AI Summary
Salarius Pharmaceuticals, Inc. filed an S-1/A on April 17, 2025, to update its business and financial information and respond to SEC comments. The company, formerly known as Flex Pharma, Inc. until July 30, 2014, is based in Houston, TX, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates ongoing regulatory engagement and potential updates to Salarius Pharmaceuticals' business strategy or financial disclosures, which could impact investor understanding and future company actions.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to capital raises or significant business changes, which carry inherent risks for investors.
Key Numbers
- 2834 — SIC Code (Indicates the company operates in Pharmaceutical Preparations.)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Filer
- Flex Pharma, Inc. (company) — Former company name
- 333-284368 (dollar_amount) — SEC file number
- 20250417 (date) — Filing date
- 20250416 (date) — Date as of change
FAQ
What specific SEC comments is Salarius Pharmaceuticals responding to in this S-1/A filing?
The filing states it is to 'respond to SEC comments' but does not detail the specific comments within the provided text.
What is the primary purpose of this S-1/A filing?
The purpose is to update business and financial information and respond to SEC comments.
When did Salarius Pharmaceuticals change its name from Flex Pharma, Inc.?
The date of the name change was July 30, 2014.
What is Salarius Pharmaceuticals' fiscal year end?
The fiscal year end is December 31.
What is the SEC file number associated with this filing?
The SEC file number is 333-284368.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on April 17, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).